Reid Merryman, Gottfried von Keudell, Robert Redd, Heather Walker, Jenna Mahns, Samantha Normilus, Siri Sagedahl, Ioulia Vogiatzi, Mingzeng Zhang, Emily Sumpena, Weihsin Chuan, Inhye Ahn, Amy Bessnow, Jennifer Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Hua-Jay Cherng, Mark Murakami, Philippe Armand, Joshua Brody. "Glofitamab and obinutuzumab (GLOBIN) as first-line therapy for patients with high-tumor burden follicular lymphoma: First results of a multicenter phase II trial." Blood, 2025. doi:10.1182/blood-2025-3602